Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06268522 · ClinicalTrials.gov registry record · NA

Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)

A NA study, sponsored by Brigham and Women's Hospital.

Completed
Registry status
NA
Development phase
121
Enrollment target

NCT06268522 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06268522, a NA study, has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
NA
Development phase
121 participants
Enrollment target

Study Summary

This study is a Randomized Controlled Trial exploring the effects of a Mindfulness interventions in reducing pain interference and opioid dose in patients with Chronic Low Back Pain. A total of 200 opioid-using patients with chronic pain, male and female participants will be enrolled, with a need for 160 completers. Patient will be randomly assigned into the Mindfulness-Oriented Recovery Enhancement or the Psychoeducation comparison control group.

Interventions

  • BEHAVIORAL Psychoeducation
  • BEHAVIORAL Mindfulness-Oriented Recovery Enhancement: (MORE) group

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2024-02-01
Est. Completion 2025-06-28
Phase NA

Sponsor

Brigham and Women's Hospital

937 total trials

What the Registry Record Tells You About NCT06268522

The ClinicalTrials.gov registry entry for NCT06268522 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Psychoeducation is the first listed.

NCT06268522 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06268522 about?

NCT06268522 is a clinical study titled "Adjunctive Mindfulness During Opioid Tapering for patientS With Chronic Pain (The AMOS Study)". This study is a Randomized Controlled Trial exploring the effects of a Mindfulness interventions in reducing pain interference and opioid dose in patients with Chronic Low Back Pain. A total of 200 opioid-using patients with chronic pain, male and female participants will be enrolled, with a need fo...

What is the current status of trial NCT06268522?

This trial is currently completed. It is a NA study. The enrollment target is 121 participants. The study started on 2024-02-01. Estimated completion is 2025-06-28.

What interventions are being tested in trial NCT06268522?

The interventions under investigation include: Psychoeducation (BEHAVIORAL), Mindfulness-Oriented Recovery Enhancement: (MORE) group (BEHAVIORAL).

Who is sponsoring clinical trial NCT06268522?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.